DarioHealth Corp. (DRIO) stock
DRIONasdaqSurgical & Medical Instruments & ApparatusFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 12, 2026Score 8/3099% below fair value
$1.15+0.00 (0.00%)
Close on Nov 17, 2026Market cap $11.27MP/E 0.3Yield –
DarioHealth operating income
Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.
DarioHealth's operating income for the twelve months ending Jun 30, 2026 was -$31.83M. For fiscal 2025 it was -$36.66M. The highest annual figure on record is -$3.97M in fiscal 2012.
Annual operating income
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$36.66M | – |
| FY2024 | Dec 31, 2024 | -$57.74M | – |
| FY2023 | Dec 31, 2023 | -$56.19M | – |
| FY2022 | Dec 31, 2022 | -$56.81M | – |
| FY2021 | Dec 31, 2021 | -$76.49M | – |
| FY2020 | Dec 31, 2020 | -$29.90M | – |
| FY2019 | Dec 31, 2019 | -$17.71M | – |
| FY2018 | Dec 31, 2018 | -$17.69M | – |
| FY2017 | Dec 31, 2017 | -$14.42M | – |
| FY2016 | Dec 31, 2016 | -$11.10M | – |
| FY2015 | Dec 31, 2015 | -$7.70M | – |
| FY2014 | Dec 31, 2014 | -$11.36M | – |
| FY2013 | Dec 31, 2013 | -$13.56M | – |
| FY2012 | Dec 31, 2012 | -$3.97M | – |
Quarterly operating income
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$6.48M | – |
| Q1 FY2026 | Mar 31, 2026 | -$7.31M | – |
| Q4 FY2025 | Dec 31, 2025 | -$8.56M | – |
| Q3 FY2025 | Sep 30, 2025 | -$9.48M | – |
| Q2 FY2025 | Jun 30, 2025 | -$9.20M | – |
| Q1 FY2025 | Mar 31, 2025 | -$9.41M | – |
| Q4 FY2024 | Dec 31, 2024 | -$11.67M | – |
| Q3 FY2024 | Sep 30, 2024 | -$12.03M | – |
| Q2 FY2024 | Jun 30, 2024 | -$16.19M | – |
| Q1 FY2024 | Mar 31, 2024 | -$17.86M | – |
| Q4 FY2023 | Dec 31, 2023 | -$14.22M | – |
| Q3 FY2023 | Sep 30, 2023 | -$15.55M | – |
| Q2 FY2023 | Jun 30, 2023 | -$14.02M | – |
| Q1 FY2023 | Mar 31, 2023 | -$12.41M | – |
| Q4 FY2022 | Dec 31, 2022 | -$9.01M | – |
| Q3 FY2022 | Sep 30, 2022 | -$14.57M | – |
| Q2 FY2022 | Jun 30, 2022 | -$17.36M | – |
| Q1 FY2022 | Mar 31, 2022 | -$15.87M | – |
| Q4 FY2021 | Dec 31, 2021 | -$21.67M | – |
| Q3 FY2021 | Sep 30, 2021 | -$22.50M | – |
| Q2 FY2021 | Jun 30, 2021 | -$18.00M | – |
| Q1 FY2021 | Mar 31, 2021 | -$14.33M | – |
| Q4 FY2020 | Dec 31, 2020 | -$9.06M | – |
| Q3 FY2020 | Sep 30, 2020 | -$6.60M | – |
| Q2 FY2020 | Jun 30, 2020 | -$4.12M | – |
| Q1 FY2020 | Mar 31, 2020 | -$10.11M | – |
| Q4 FY2019 | Dec 31, 2019 | -$4.18M | – |
| Q3 FY2019 | Sep 30, 2019 | -$2.80M | – |
| Q2 FY2019 | Jun 30, 2019 | -$5.36M | – |
| Q1 FY2019 | Mar 31, 2019 | -$5.36M | – |
| Q4 FY2018 | Dec 31, 2018 | -$4.93M | – |
| Q3 FY2018 | Sep 30, 2018 | -$4.05M | – |
| Q2 FY2018 | Jun 30, 2018 | -$5.79M | – |
| Q1 FY2018 | Mar 31, 2018 | -$2.92M | – |
| Q4 FY2017 | Dec 31, 2017 | -$3.12M | – |
| Q3 FY2017 | Sep 30, 2017 | -$2.98M | – |
| Q2 FY2017 | Jun 30, 2017 | -$4.12M | – |
| Q1 FY2017 | Mar 31, 2017 | -$4.21M | – |
| Q4 FY2016 | Dec 31, 2016 | -$3.83M | – |
| Q3 FY2016 | Sep 30, 2016 | -$2.72M | – |
See a number that looks wrong?